Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation

SIMPLE SUMMARY: Glioblastoma (GBM) is considered the deadliest brain tumor; with patients displaying a high incidence of relapse and a 3-year survival of only 3–5%. For these reasons, investigation of the molecular basis of the disease could provide novel targets for therapy and improve patient prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Rampazzo, Elena, Manfreda, Lorenzo, Bresolin, Silvia, Cani, Alice, Mariotto, Elena, Bortolozzi, Roberta, Della Puppa, Alessandro, Viola, Giampietro, Persano, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027190/
https://www.ncbi.nlm.nih.gov/pubmed/35454804
http://dx.doi.org/10.3390/cancers14081897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027190/
https://www.ncbi.nlm.nih.gov/pubmed/35454804
http://dx.doi.org/10.3390/cancers14081897

Ejemplares similares